Whay IM KAM's were cut?










Word on the street is that it was deep

Pfizer Inc. (NYSE:PFE)​

Number of Hedge Fund Holders In Q3 2024: 80

Pfizer Inc. (NYSE:pFE) is one of the most well-known drug companies in the world. Its shares haven't performed well at all in 2024 and are down 8% year-to-date. Pfizer Inc. (NYSE:pFE)'s heft has also led to it accumulating significant debt. As of 2023 end, the firm's long-term debt was $61.5 billion. Debt impacts the bottom line, and for firms like Pfizer Inc. (NYSE:pFE) this means that dividends suffer. As a result, the firm has spent 2024 spinning off its business to raise cash and retire its debt. It has also faced pressure from activist investor Starboard over costly acquisitions that haven't yielded profitable drugs. Cramer's comments surrounded Pfizer Inc. (NYSE:pFE) CEO's strategy for a turnaround and its 2025 earnings projection as he outlined:

"That's very impressive.

"And I, you know what I think that Dr. Bourla, he's done a lot of good worldwide. He's done many things that I think are very positive for healthcare. I think that the issue has been, what about the numbers? Can he make the numbers?
Pressure :) Pfizer Pfun
 


Pfizer Inc. (NYSE:PFE)​

Number of Hedge Fund Holders In Q3 2024: 80

Pfizer Inc. (NYSE:pFE) is one of the most well-known drug companies in the world. Its shares haven't performed well at all in 2024 and are down 8% year-to-date. Pfizer Inc. (NYSE:pFE)'s heft has also led to it accumulating significant debt. As of 2023 end, the firm's long-term debt was $61.5 billion. Debt impacts the bottom line, and for firms like Pfizer Inc. (NYSE:pFE) this means that dividends suffer. As a result, the firm has spent 2024 spinning off its business to raise cash and retire its debt. It has also faced pressure from activist investor Starboard over costly acquisitions that haven't yielded profitable drugs. Cramer's comments surrounded Pfizer Inc. (NYSE:pFE) CEO's strategy for a turnaround and its 2025 earnings projection as he outlined:

"That's very impressive.


Pressure :) Pfizer Pfun
What’ve

Pfizer Inc. (NYSE:PFE)​

Number of Hedge Fund Holders In Q3 2024: 80

Pfizer Inc. (NYSE:pFE) is one of the most well-known drug companies in the world. Its shares haven't performed well at all in 2024 and are down 8% year-to-date. Pfizer Inc. (NYSE:pFE)'s heft has also led to it accumulating significant debt. As of 2023 end, the firm's long-term debt was $61.5 billion. Debt impacts the bottom line, and for firms like Pfizer Inc. (NYSE:pFE) this means that dividends suffer. As a result, the firm has spent 2024 spinning off its business to raise cash and retire its debt. It has also faced pressure from activist investor Starboard over costly acquisitions that haven't yielded profitable drugs. Cramer's comments surrounded Pfizer Inc. (NYSE:pFE) CEO's strategy for a turnaround and its 2025 earnings projection as he outlined:

"That's very impressive.


Pressure :) Pfizer Pfun
what KAMs were cut? It has been quiet
 

















Write your reply...